The cardiac implants market is witnessing significant growth, largely due to the increasing prevalence of cardiovascular diseases (CVDs), the most common cause of death in the world. In 2023, cardiovascular diseases (CVDs) were responsible for 32% of all global deaths, or 17.9 million deaths according to the World Health Organization (WHO). Countries worldwide are taking countermeasures by expenditure on healthcare facilities development and planned activities to control CVDs. For instance, in 2023 the US HHS invested USD 10 billion in decreasing large population heart-related deaths via new medical technology offerings such as cardiac implants.